TABLE 4.

Association between SLC11A1 polymorphisms and the TB risk stratified by gender.

SNP-ID	Model	Genotype	Male		Female
			OR (95% CI)	P	OR (95% CI)	P
rs7608307	Co-dominant	CC	1		1
		CT	1.69 (1.12–2.56)	0.013	0.75 (0.46–1.23)	0.255
		TT	0.79 (0.17–3.56)	0.753	—	—
	Dominant	CC	1		1
		CT-TT	1.61 (1.08–2.41)	0.020	0.73 (0.45–1.20)	0.219
	Recessive	CC-CT	1		1
		TT	0.72 (0.16–3.24)	0.666	—	—
	Log-additive	--	1.47 (1.01–2.13)	0.043	0.72 (0.44–1.17)	0.185
rs4674301	Co-dominant	TT	1		1
		TC	0.89 (0.63–1.26)	0.508	0.98 (0.63–1.51)	0.921
		CC	0.77 (0.36–1.63)	0.490	3.82 (1.04–4.03)	0.043
	Dominant	TT	1
		TC-CC	0.87 (0.63–1.21)	0.414	1.11 (0.73–1.69)	0.626
	Recessive	TT-TC	1
		CC	0.79 (0.37–1.68)	0.546	3.85 (1.06–4.02)	0.041
	Log-additive	--	0.88 (0.67–1.16)	0.371	1.24 (0.86–1.78)	0.249
rs13062	Co-dominant	CC	1		1
		CA	1.52 (1.10–2.12)	0.012	0.98 (0.64–1.49)	0.914
		AA	0.76 (0.42–1.36)	0.352	0.64 (0.29–1.41)	0.269
	Dominant	CC	1		1
		CA-AA	0.79 (0.37–1.68)	0.546	0.91 (0.61–1.37)	0.663
	Recessive	CC-CA	1		1
		AA	0.63 (0.36–1.10)	0.104	0.65 (0.30–1.39)	0.267
	Log-additive	--	1.10 (0.86–1.40)	0.453	0.88 (0.64–1.20)	0.414

CI: confidence interval; OR: odds ratio; SNP: single-nucleotide polymorphism; TB: tuberculosis. p < 0.05 indicates statistical significance.